What is ADVATE?
ADVATE is a plasma/albumin-free recombinant factor VIII replacement therapy for patients with hemophilia A.1,3
LIFE
HAPPENS
ADVATE® WILL BE THERE WHEN IT DOES
Indications and Limitations of Use: ADVATE [Antihemophilic Factor (Recombinant)] is a recombinant antihemophilic factor indicated for use in children and adults with hemophilia A for the control and prevention of bleeding episodes. ADVATE is not indicated for the treatment von Willebrand disease.
LEARN MORE*In clinical trials, ADVATE has demonstrated the ability to help patients prevent bleeding episodes using a prophylaxis regimen.
CONTRAINDICATIONS: Patients who have life-threatening hypersensitivity reactions, including anaphylaxis, to mouse or hamster protein or other constituents of the product.
Please see additional detailed important risk information below.
ADVATE is a plasma/albumin-free recombinant factor VIII replacement therapy for patients with hemophilia A.1,3
SELECTED IMPORTANT RISK INFORMATION
WARNINGS & PRECAUTIONS
Hypersensitivity reactions: Allergic-type hypersensitivity reactions, including anaphylaxis, have been reported with ADVATE. Symptoms include dizziness, paresthesia, rash, flushing, facial swelling, urticaria, dyspnea, pruritus, and vomiting. Discontinue ADVATE if hypersensitivity symptoms occur and administer appropriate emergency treatment.
Please see additional detailed important risk information below.
Intended for ADVATE patients 16 years and older with a body weight of 45 kg or greater, myPKFiT enables a personalized approach to prophylaxis treatment.5,6
Learn MoremyPKFiT is not indicated for the treatment of von Willebrand disease and should not be used for patients who have developed neutralizing antibody to FVIII products. myPKFiT is Rx only. For safe and proper use of the myPKFiT software, please refer to the complete instructions for use in the User Manual.
Please see the full intended use statement for myPKFiT below.
You are being directed to ADVATEPro.com. The information on
this website is intended for U.S. healthcare professionals only.